We highly recommend the PreserVision AREDS 2 Eye Vitamin & Mineral Supplement to anyone looking for an eye health supplement. We found that the Focus Select AREDS2 Based Eye Vitamin-Mineral ...

The potential sale of its 88% stake in Bausch + Lomb could generate billions for creditors and shareholders of the indebted ...

Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout ...

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

RECOMMENDED FORMULA: This formula includes lutein, zeaxanthin, zinc, copper, vitamin C, and vitamin E to exactly match the nutrient formula recommended by the AMD experts at the National Eye ...

RECOMMENDED FORMULA: This formula includes lutein, zeaxanthin, zinc, copper, vitamin C, and vitamin E to exactly match the nutrient formula recommended by the AMD experts at the National Eye ...

The Salix division, which pertains to gastroenterology, has been the company's most profitable division after Bausch + Lomb, ...

Investing.com -- Bausch + Lomb (NYSE:BLCO) is exploring a potential ... This has caused its market value to fall to $2.2 billion, raising concerns about the company's financial stability.

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third ...

Monday was an eventful day for Bausch + Lomb (NYSE: BLCO). The eye care specialist's major piece of internal news was that it earned its latest Food and Drug Administration (FDA) approval.

1,2* VAUGHAN, Ontario, May 29, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people see better to ...